Saturday, April 17, 2021
wellness India Expo
Home Tags Bharat Biotech

Tag: Bharat Biotech

Govt targets 6-7 fold increase in COVAXIN production by August, 2021

The current production capacity of indigenously developed Covaxin vaccine is expected to be doubled by May-June 2021 and then increased nearly 6-7 fold by July - August 2021 under Mission COVID Suraksha......................

Govt fast tracks emergency approvals for foreign produced COVID-19 vaccines

A lot many vaccines are expected to be granted Emergency Use Authorization in other countries for expanding the basket of vaccines for domestic use and hasten the pace and coverage of vaccination....................

Bharat Biotech’s COVAXIN Phase 3 results show interim clinical efficacy of...

Data from 25,800 participants that received the COVAXIN vaccine or placebo in a 1:1 ratio showed that the vaccine candidate was well-tolerated. It demonstrated 81% interim efficacy in preventing COVID-19 after the second dose....................

Bharat Biotech confirms deal with Brazil to supply 20 million doses...

It has signed an agreement for the delivery of COVAXIN during the second and third quarter of the year 2021.....................

Ukraine Health Minister visits Bharat Biotech vaccine plant at Hyderabad

The representatives from the Central Asian nation of 41 million people took a tour of the world-class Bio-Safety Level 3 manufacturing facility....................

BioAsia 2021 to honor Bharat Biotech with Genome Valley Excellence Award

Dr Krishna M. Ella, Mrs.Suchitra Ella and Dr Balram Bhargav are being honored in BioAsia 2021...............

Approval in India paves way for Bharat Biotech to take Covaxin...

Recently, Bharat Biotech has applied for regulatory approval to conduct clinical trials in Bangladesh and has applied for EUA in the Philippines.....................

Bharat Biotech signs deal with Ocugen to commercialize Covaxin in US...

Ocugen to receive an initial supply of COVAXIN™ doses from Bharat Biotech upon authorization from US regulatory authorities while it ramps up manufacturing in the US. The vaccine is currently in a fully enrolled Phase 3 clinical trial involving 25,800 patients...........

#Budget2021: Stakeholders welcome Rs 35,000 crore outlay for COVID-19 vaccines

Experts believe that the largest ever allocation in the history of the vaccine industry would catalyze research and development efforts in the area....................

GSK, PATH & Bharat Biotech sign product transfer agreement over malaria...

Bharat Biotech to produce antigen for world’s first vaccine against Plasmodium falciparum malaria following technology transfer, to help ensure long-term sustainable supply. Transfer builds on GSK commitments to donate up to 10 million vaccine doses.......................